The above is the Profit and loss balance sheet financial data for AMPOL from 2020-22. We need to calculate Liquidity ratios (current and quick); Activity ratios, Debt ratios, profitability ratios, profitability ratios (DuPont method) and market ratios for 2020, 21 and 22.

Item	12/20	12/21	12/22
Operating Revenue	15,175,600,000	21,420,900,000	38,245,400,000
COGS	-14,200,500,000	-19,389,800,000	-35,679,600,000
Gross Profit	975,100,000	2,031,100,000	2,565,800,000
Other Revenue	297,800,000	275,900,000	251,400,000
Total Revenue Excluding Interest	1,272,900,000	2,307,000,000	2,817,200,000
Operating Expenses	-880,200,000	-993,500,000	-1,250,900,000
EBITDA	392,700,000	1,313,500,000	1,566,300,000
Depreciation	-531,800,000	-363,900,000	-400,100,000
Amortisation	-27,900,000	-17,100,000	-38,300,000
Depreciation and Amortisation	-559,700,000	-381,000,000	-438,400,000
EBIT	-167,000,000	932,500,000	1,127,900,000
Interest Revenue	600,000	400,000	76,900,000
Interest Expense	-109,700,000	-113,100,000	-183,900,000
Net Interest Expense	-109,100,000	-112,700,000	-107,000,000
PreTax Profit	-276,100,000	819,800,000	1,020,900,000
Tax Expense	245,800,000	-199,600,000	-184,500,000
Net Profit after Tax Before Abnormals	-30,300,000	620,200,000	836,400,000
Abnormals	-449,500,000	-22,700,000	-84,400,000
Abnormals Tax	0	0	26,600,000
Net Abnormals	-449,500,000	-22,700,000	-57,800,000
Reported NPAT After Abnormals	-479,800,000	597,500,000	847,000,000
Outside Equity Interests	-5,100,000	-37,500,000	-51,100,000
Shares Outstanding at Period End	249,700,000	238,300,000	238,300,000
Weighted Average Number of Shares	249,700,000	238,300,000	238,300,000
EPS Adjusted (cents/share)	-14.18	242.97	327.87
EPS After Abnormals (cents/share)	-194.19	233.50	332.30
Price per share @31 Dec	25.2	24.04	27.10
Item	12/20	12/21	12/22
CA - Cash	367,600,000	566,300,000	126,000,000
CA - Receivables	859,800,000	1,576,200,000	2,601,100,000
CA - Prepaid Expenses	0	0	0
CA - Inventories	1,333,600,000	2,064,900,000	3,593,900,000
CA - Investments	0	0	0
CA - NCA Held Sale	0	0	0
CA - Other	50,900,000	0	0
Total Current Assets	2,611,900,000	4,207,400,000	6,321,000,000
NCA - Receivables	2,500,000	41,500,000	118,100,000
NCA - Inventories	0	0	0
NCA - Investments	173,000,000	184,000,000	305,400,000
NCA - PP&E	3,467,700,000	3,564,700,000	4,617,700,000
NCA - Intangibles(ExGW)	152,700,000	99,600,000	925,900,000
NCA - Goodwill	405,700,000	406,700,000	673,300,000
NCA - Future Tax Benefit	453,800,000	344,200,000	366,100,000
NCA - Other	50,600,000	5,600,000	3,700,000
Total NCA	4,706,000,000	4,646,300,000	7,010,200,000
Total Assets	7,317,900,000	8,853,700,000	13,331,200,000
CL - Account Payable	1,489,100,000	2,370,200,000	4,438,200,000
CL - Short-Term Debt	160,200,000	159,600,000	503,700,000
CL - Provisions	334,500,000	364,300,000	512,500,000
CL - NCL Held Sale	0	0	0
CL - Other	0	0	0
Total Curr. Liabilities	1,983,800,000	2,894,100,000	5,454,400,000
NCL - Account Payable	16,000,000	12,800,000	52,200,000
NCL - Long-Term Debt	1,555,500,000	2,104,000,000	3,110,700,000
NCL - Provisions	537,900,000	496,000,000	663,800,000
NCL - Other	0	0	0
Total NCL	2,109,400,000	2,612,800,000	3,826,700,000
Total Liabilities	4,093,200,000	5,506,900,000	9,281,100,000
Net Assets	3,224,700,000	3,346,800,000	4,050,100,000
Share Capital	501,000,000	478,200,000	476,900,000
Reserves	5,600,000	65,500,000	209,100,000
Retained Earnings	2,444,500,000	2,531,000,000	2,946,000,000
Other Equity	0	0	0
Equity Avail for Ordinary Shareholders	2,951,100,000	3,074,700,000	3,632,000,000
Convertible Equity	0	0	0
SE Held Sale	0	0	0
Outside Equity	273,600,000	272,100,000	418,100,000
Total Equity	3,224,700,000	3,346,800,000	4,050,100,000